SCHEMBL30229795

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	REN	P00797	10/20	0.54

▸	MAPK8	P45983	1/20	0.53

▸	MAPK9	P45984	1/20	0.53

▸	MAPK10	P53779	1/20	0.53

▸	OPRM1	P35372	2/20	0.51

▸	OPRK1	P41145	2/20	0.51

▸	CTSL	P07711	2/20	0.51

▸	CTSS	P25774	2/20	0.51

▸	CTSK	P43235	2/20	0.51

▸	CTSH	P09668	1/20	0.51

▸	KDM1A	O60341	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30229797	0.93	MAPK8 (0.46)	RENMAPK8MAPK9MAPK10OPRM1
SCHEMBL30230017	0.93	OPRM1 (0.58)	OPRM1OPRK1CTSLCTSSCTSK
SCHEMBL30229850	0.92	REN (0.56)	RENMAPK8MAPK9MAPK10OPRM1
SCHEMBL30229695	0.92	REN (0.56)	RENMAPK8MAPK9MAPK10OPRM1
SCHEMBL30504861	0.91	OPRM1 (0.53)	OPRM1OPRK1CTSLCTSSCTSK
SCHEMBL22022379	0.91	OPRM1 (0.53)	OPRM1OPRK1CTSLCTSSCTSK
SCHEMBL29607547	0.90	REN (0.53)	RENMAPK8MAPK9MAPK10KDM1A
SCHEMBL29607022	0.89	KDM1A (0.52)	RENMAPK8MAPK9MAPK10KDM1A
SCHEMBL16212659	0.88	C5AR1 (0.54)	OPRM1OPRK1CTSLCTSSCTSK
SCHEMBL30504860	0.87	C5AR1 (0.52)	RENMAPK8MAPK9MAPK10OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11560406-B2	Anti-androgen peptides and uses thereof in cancer therapy	CANCER RESEARCH TECHNOLOGY LIMITED (GB)	2023-01-24	—	—	US	disclosed